Transcutaneous bilirubin measurement in healthy Saudi term newborns

References

1. ↵
   1. Alsedi SA

   (2016) Transcutaneous bilirubin measurement in healthy Saudi term newborns. Saudi Med J 37:142–146.

   OpenUrlAbstract/FREE Full Text
2. ↵
   1. Ambalavanan NR,
   2. Carlo WA,
   3. Jaundice and Hyperbilirubinemia

   (2016) Nelson Textbook of Pediatrics (ELSEVIER, Philadelphia (US)), 20th ed, pp 871–875.
3. ↵
   1. Gamaleldin R,
   2. Iskandar I,
   3. Seoud I,
   4. et al.

   (2011) Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia. Pediatrics 128:e925.

   OpenUrlAbstract/FREE Full Text
4. ↵
   1. Newman TB,
   2. Xiong B,
   3. Gonzales VM,
   4. Escobar GJ

   (2000) Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatric Adolescence Med 154:1140.

   OpenUrl
5. ↵
   1. American Academy of Pediatrics. Subcommittee on hyperbilirubinemia. Clinical practice guideline, management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation

   (2004) Pediatrics 114:297–316.

   OpenUrlAbstract/FREE Full Text
6. ↵
   1. Bhutani VK,
   2. Johnson L,
   3. Sivieri EM

   (1999) Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy-term and near-term newborns. Pediatrics 103:6–14.

   OpenUrlAbstract/FREE Full Text
7. ↵
   1. Maisels MJ,
   2. DeRidder JM,
   3. Kring EA,
   4. Balasubramaniam M

   (2009) Routine transcutaneous bilirubin measurments combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia. Journal of perinatology 29:612–617.

   OpenUrl